Hendri Tjandra is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII conjugates. With a total of 3 patents to his name, Tjandra's work has the potential to impact the treatment of hemophilia and other related disorders.

Latest Patents

Tjandra's latest patents focus on Factor VIII muteins that are covalently bound to biocompatible polymers such as polyethylene glycol. These inventions are designed to retain FVIII procoagulant activity while improving pharmacokinetic properties. The innovative approach of binding at a predefined site that is not an N-terminal amine enhances the effectiveness of these conjugates in therapeutic applications.

Career Highlights

Hendri Tjandra is currently employed at Bayer Healthcare LLC, where he continues to advance his research and development efforts. His work at Bayer has allowed him to collaborate with leading experts in the field and contribute to groundbreaking innovations in healthcare.

Collaborations

Some of Tjandra's notable coworkers include Clark Qun Pan and John E Murphy. Their collaborative efforts have further enriched the research environment and fostered innovation within the company.

Conclusion

Hendri Tjandra's contributions to biotechnology through his patents on Factor VIII conjugates demonstrate his commitment to improving medical treatments. His work not only showcases his inventive spirit but also highlights the importance of collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.